This article is educational, not legal advice. If you have received a Form 483 with five or more observations, or any observation you intend to contest, get a regulatory attorney involved before you respond.
01First, breathe
What an FDA Form 483 actually is.
The FDA inspector who just left your facility handed you a multi-page document with "FDA Form 483" printed at the top. The sentence underneath the form number is the only one most operators don't read carefully, and it's the one that matters:
"This document lists observations made by the FDA representative(s) during the inspection of your facility. They are inspectional observations, and do not represent a final Agency determination regarding your compliance."
That sentence is your starting point. A Form 483 is not a verdict. It is not a warning letter. It is not a fine. It is a list of things the inspector saw on the day they were there that they believe may violate the Food, Drug, and Cosmetic Act. The legal basis is 21 USC §374(b) — section 704 of the FD&C Act — which authorizes FDA inspectors to record observations and present them to the management at the close of an inspection.
I have not personally received an FDA Form 483. I have sat across a CFIA inspector reading me a list of non-conformances against my Preventive Control Plan in Brantford, and the panic in the room is the same. The discipline of how you respond in the next 15 business days determines what comes next: nothing, a follow-up inspection, a warning letter, or — in the worst case — an injunction. The first response is not panic. The first response is to understand what you're holding.
02The clock
You have 15 business days.
The FDA's expectation, codified in their inspection guidance, is that you respond to a Form 483 within 15 business days. Business days, not calendar days. The day the form was issued is "Day 0" and does not count. Federal holidays do not count. Saturdays and Sundays do not count.
Count the days carefully
Day 0 = the day the inspector closed out. Day 1 = the next business day. Day 15 = the deadline to email or postmark your response to the FDA district office that conducted the inspection. Late responses are processed differently and are weighted negatively in the eventual classification decision.
This timeline is not statutory. There is no law that says you must respond in 15 business days, or at all. The 15-day window is FDA policy. In practice, every regulatory attorney and every PCQI you talk to will tell you the same thing: treat the deadline as mandatory. The single best predictor of whether a 483 escalates to a warning letter is whether the firm responded within 15 business days with corrective actions and evidence.
03483 vs warning letter
How a 483 is different from a warning letter.
A Form 483 and a warning letter are sometimes treated as the same thing. They are not. The differences matter for how you respond and what your customers will see.
Form 483
Private
Issued by the inspector at the close of the inspection. Lists observations. Not posted publicly. Not the FDA's final position. Response is voluntary.
Warning letter
Public
Issued by the FDA district office weeks or months later, after the 483 and your response have been reviewed by FDA legal. Posted publicly on fda.gov. Cites specific regulations the FDA believes you violated.
After the inspection, the FDA classifies it into one of three buckets:
- 01
NAI — No Action Indicated
The inspection found no objectionable conditions, or the issues were minor and closed at the time of inspection. Most inspections end here.
- 02
VAI — Voluntary Action Indicated
The inspection found objectionable conditions, but they don't warrant regulatory action. The firm is expected to fix them. Most Form 483s land in this category.
- 03
OAI — Official Action Indicated
The objectionable conditions are serious enough to warrant regulatory action — typically a warning letter, in extreme cases an import alert, an injunction, or a seizure.
According to FDLI's 2024 analysis of FDA inspection data, about 1% of FDA human food preventive-controls inspections result in OAI. About 3.1% of animal food inspections do. The vast majority of Form 483s do not become warning letters — but the ones that do almost always involve either a missed 15-day response or a response that didn't satisfy the FDA.
04Voluntary
Do you have to respond? Technically no.
The FDA's own guidance describes the response to a Form 483 as voluntary. There is no statutory requirement to respond. There is no fine for ignoring it.
There is also no statutory requirement to wear a seatbelt in some states, but you wear one anyway. The 15-day response is the same kind of "voluntary."
A response window of 15 business days, with a substantive response and evidence of corrective action, is the single best predictor of an NAI/VAI classification. A non-response, a late response, or a response that hand-waves at the observations is the single best predictor of OAI escalation. The FDA staff who decide the classification have explicit guidance to weigh "firm response" as a factor.
“
Yes, technically the response is voluntary. So is wearing a seatbelt. Choose to respond.
”Regulatory attorney/Common counsel to firms with a fresh 483
05The common observations
The seven most-cited food observations.
If you operate a registered food facility under FSMA, the seven 483 observations FDA cited most often in human-food inspections (FY 2019 to 2023) all map to specific paragraphs of 21 CFR Part 117:
- 01
Sanitary operations
The facility was not maintained in a clean and sanitary condition. Most-cited human-food observation overall — 100 citations in FDA human food warning letters 2017 to 2023.
§117.35(a) - 02
Pest control
Pests not effectively excluded from the facility. Rodent droppings, bird ingress, insect activity. The bait-station-with-no-log version of this observation appears constantly.
§117.35(c) - 03
Hazard analysis gaps
The written hazard analysis did not consider all known or reasonably foreseeable hazards. Missing chemical hazards. Missing allergen cross-contact. Missing environmental pathogens.
§117.130 - 04
Preventive controls missing or inadequate
The preventive controls in your Food Safety Plan don't actually control the hazards the analysis identified. 81 citations in warning letters in the FY17-23 window.
§117.135 - 05
Equipment design and maintenance
Equipment was poorly designed, in disrepair, or impossible to clean. Pitted prep surfaces, broken gaskets, missing guards.
§117.40 - 06
Personnel hygiene and training
Employee handwashing, garment cleanliness, or jewelry policies inadequate. Often paired with missing training records.
§117.10 - 07
Environmental monitoring (RTE facilities)
Ready-to-eat-food facilities not running an environmental Listeria monitoring program, or running one but not following up on findings.
§117.165
If your facility makes food for animals, the analogous 483 observations sit under 21 CFR Part 507 (preventive controls for animal food).
06The response letter
How to structure your response.
A response letter that satisfies the FDA has six components. Build them in this order:
- 01
Cover letter from executive management
Signed by the most senior person at the facility — owner, plant manager, or general manager. Not the QA manager alone. The FDA reads the signature as a signal of how seriously the company takes the observations.
- 02
Executive summary
One page. List each observation, your concur/contest decision, the corrective action taken, and the date the corrective action was completed (or the planned completion date).
- 03
Observation-by-observation response
Restate the observation verbatim. State whether you concur (agree) or contest (disagree). If you contest, you need evidence to support the contestation — usually photographs, records, or a corrected logbook from the day of the observation.
- 04
Communication plan
How you'll keep the FDA informed of progress on any corrective actions that aren't fully completed yet. Typically a status update every 30 or 60 days.
- 05
Evidence attachments
Photographs of completed work, calibration records, signed training certificates, updated procedures, SOP revision history. Numbered so each piece of evidence ties to an observation.
- 06
Signed certifications where required
If your facility holds USDA inspection on top of FDA, certain observations require a separately-signed corrective action certification from a qualified individual.
07The CAPA structure
What each observation response must include.
For every observation you concur with, the FDA wants to see the same five things:
- 01
Restate the observation verbatim
Copy the inspector's text exactly. Don't paraphrase. Don't soften.
- 02
Immediate corrective action
What you did to fix the specific instance — the room you cleaned, the equipment you repaired, the record you back-filled. With date completed.
- 03
Root cause analysis
Use the “5 Whys” technique — ask “why?” five times to get past the surface symptom. Example: Why was the pest log missing entries? Because the pest control technician didn't sign on the last visit. Why? Because the new technician wasn't trained on our log format. Why? Because we didn't have a documented training procedure for vendor staff. Why? Because the SOP only covered our own employees. Why? Because vendors were never considered part of the training scope. The root cause is the training-scope gap, not the missing signature.
- 04
Corrective and Preventive Action (CAPA)
CAPA = the systemic change you're making so this doesn't happen again anywhere else in the facility. Updated SOP, new training, added equipment, revised supplier qualification. Specific. Dated.
- 05
Effectiveness verification
How you'll prove the CAPA actually worked. Usually a follow-up audit at 30 or 90 days. State the date and the verification method.
What this means for you
The biggest difference between a 483 that closes and a 483 that escalates is whether the response includes a credible root cause analysis. Inspectors expect you to look past the specific instance to the system that allowed it. A response that fixes only the surface symptom — "we re-trained the employee, signed by Date" — usually triggers a follow-up inspection. A response that traces the symptom to a documented system gap and updates the system usually doesn't.
08Mistakes that escalate
The 11 mistakes that get firms warning-lettered.
These are the response failures that, in FDA's published warning letters, are most often called out as reasons the response was insufficient:
- 01
Missing the 15-business-day deadline
The single most reliable predictor of escalation.
- 02
Contesting observations without evidence
You can disagree, but only if you can prove it. A contested observation with no supporting evidence is treated as a non-response.
- 03
Treating each observation in isolation
If multiple observations point to the same root cause — say, three sanitation failures in different parts of the plant — your response needs to address the underlying program, not just the three instances.
- 04
No root cause analysis
“We re-trained the employee” with no analysis of why the training gap existed.
- 05
No effectiveness verification plan
Corrective action stated but no plan for how you'll know it actually worked.
- 06
QA manager signature only
Executive management didn't sign the cover letter, which the FDA reads as a sign the response isn't company-wide.
- 07
Vague timelines
“We will improve our pest control program” without a specific completion date.
- 08
Weak evidence
Photographs without timestamps, records without signatures, “training completed” claims without attendance lists.
- 09
Ignoring the close-out narrative
The inspector wrote a context paragraph at the close-out. Your response should address it, not just the bulleted observations.
- 10
No follow-up after the response
If you said you'd send a 30-day update, send it on day 30 — not day 45. The FDA tracks the follow-up commitments.
- 11
Self-incriminating or evasive language
Phrases like “we have always done it this way” or “the inspector misunderstood our process” without evidence read as defensive rather than corrective. Stick to facts.
09The leverage move
The annotated 483 most operators miss.
At the close-out meeting — the conversation between the inspector and your management at the very end of the inspection — the inspector can mark observations as "annotated." Annotations include:
- Corrected and verified at the time of inspection (you fixed it on the spot, the inspector confirmed)
- Reported corrected, not verified (you said you'd fix it, the inspector hasn't confirmed)
- Promised to correct (you committed to fix it by a specific date)
An annotation is not the same as removing the observation, but it materially affects how the FDA weighs the 483. Most first-time recipients of a 483 don't know they can ask. If something was genuinely corrected during the inspection — a leaking pipe was sealed, a thermometer was recalibrated, a missing log was back-filled with the inspector watching — ask the inspector at close-out to annotate it accordingly. The worst they can say is no.
10The day-by-day plan
The 15 business days, by the calendar.
This is the operational checklist if you have just been handed a 483 today.
- 01
Day 0 (today)
Inspector leaves. Make a clean photocopy of the 483 and the close-out narrative. Don't mark up the original.
- 02
Day 1
Convene the response team — owner, QA lead, plant manager, regulatory counsel if applicable. Schedule a daily 30-minute standup for the next two weeks.
- 03
Day 2
For each observation, assign an owner. Start the immediate-corrective-action work on the highest-severity observations first.
- 04
Day 3 to Day 5
Complete immediate corrective actions. Photograph and date-stamp evidence as you go.
- 05
Day 6 to Day 8
Root cause analysis (5 Whys) for each observation. Draft the systemic CAPA for each.
- 06
Day 9 to Day 11
Update SOPs, complete training, install equipment fixes. Capture evidence.
- 07
Day 12
Draft response letter, observation-by-observation. Internal QA review.
- 08
Day 13
Executive management review. Final edits.
- 09
Day 14
Final assembly: cover letter, executive summary, observation responses, evidence pack. Number every attachment.
- 10
Day 15
Send the response by certified mail or via the FDA district office's submission system. Keep proof of delivery.
After day 15, log the date of every follow-up commitment you made (30-day update, 60-day update, etc.). Treat them as hard deadlines.
Footnotes
1.FDA, Form 483 Frequently Asked Questions — fda.gov
2.FDA, Inspection Classifications — fda.gov
3.21 USC §374 (FD&C Act §704) — law.cornell.edu
4.21 CFR Part 117 — ecfr.gov
5.FDLI, “Analysis of FY19-FY23 FDA Inspection Outcomes” (March 2024) — Food and Drug Law Institute briefing
Andrew Langevin·CFIA-licensed facility, Brantford ON· Published 2026-06-03· 14 min read· Wikidata Q139112497